Eli Lilly escalates legal fight against black market for experimental weight-loss drug retatrutide
Eli Lilly is stepping up legal action against a booming black market for retatrutide, an experimental weight-loss drug the company is counting on to expand its franchise beyond approved medications like Zepbound.
